Comprehensive Complication Index

How it works

Comparisons

Evidence quality

Other

Highlighted claims

• The primary endpoint is the Comprehensive Complication Index score on postoperative day 28. — Efficacy of intraoperative use of 20% albumin in combination with Ringer’s lactate versus Ringer’s lactate during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: protocol for a randomised controlled, open-label clinical trial (ALBUCHIP trial)
• CCI is a continuous 0–100 scale that combines all postoperative complications and their severity into one morbidity measure. — Efficacy of intraoperative use of 20% albumin in combination with Ringer’s lactate versus Ringer’s lactate during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: protocol for a randomised controlled, open-label clinical trial (ALBUCHIP trial)
• All CCI component complications are adjudicated by an independent blinded committee. — Efficacy of intraoperative use of 20% albumin in combination with Ringer’s lactate versus Ringer’s lactate during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: protocol for a randomised controlled, open-label clinical trial (ALBUCHIP trial)
• The article states that CCI is more sensitive than Clavien-Dindo for cumulative complication burden and correlates with hospital stay length in CRS-HIPEC patients. — Efficacy of intraoperative use of 20% albumin in combination with Ringer’s lactate versus Ringer’s lactate during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: protocol for a randomised controlled, open-label clinical trial (ALBUCHIP trial)